Published in Br J Cancer on September 01, 2001
Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World J Gastroenterol (2003) 0.83
PTOP and TRF1 help enhance the radio resistance in breast cancer cell. Cancer Cell Int (2014) 0.78
Reduced expression of TRF1 is associated with tumor progression and poor prognosis in oral squamous cell carcinoma. Exp Ther Med (2010) 0.78
Clinical significance of telomere length and associated proteins in oral cancer. Biomark Insights (2007) 0.76
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell (1985) 24.17
Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 20.48
Telomerase catalytic subunit homologs from fission yeast and human. Science (1997) 12.35
Mammalian telomeres end in a large duplex loop. Cell (1999) 12.12
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J (1992) 10.97
A survey of telomerase activity in human cancer. Eur J Cancer (1997) 10.84
TRF2 protects human telomeres from end-to-end fusions. Cell (1998) 10.13
The RNA component of human telomerase. Science (1995) 9.86
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell (1997) 8.74
Control of telomere length by the human telomeric protein TRF1. Nature (1997) 7.62
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet (1997) 6.69
Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet (1997) 4.95
A human telomeric protein. Science (1995) 4.77
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol (1998) 4.59
A mammalian telomerase-associated protein. Science (1997) 4.37
Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res (1997) 4.22
TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell (1997) 3.30
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet (1998) 3.01
Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet (1998) 2.56
Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res (1998) 2.08
Telomerase activity in human breast tumors. J Natl Cancer Inst (1996) 1.73
Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res (1998) 1.24
Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer (1999) 1.09
Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system. Clin Chem (1998) 0.96
Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cells. Pancreas (1996) 0.86
Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation. Mutat Res (1998) 0.85
Induction of telomerase activity by in vivo X-irradiation of mouse splenocytes and its possible role in chromosome healing. Mutat Res (1998) 0.85
Establishment of quantitative reverse transcription--polymerase chain reaction assays for human telomerase-associated genes. Clin Chim Acta (2000) 0.83
Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity in pancreatic carcinoma cells via enhancement of the heart shock element-binding activity of heart shock factor 1. Chemotherapy (1997) 0.81
Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria. Gene (1988) 18.10
Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science (1999) 7.12
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA (2001) 5.43
The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J (1996) 5.09
Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol (2001) 4.96
Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell (1993) 4.46
p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett (1997) 4.31
The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature (1989) 4.13
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
Role of citron kinase as a target of the small GTPase Rho in cytokinesis. Nature (1998) 3.55
Safe right subclavian vein puncture: the importance of pressing the skin with the left thumb. Am J Emerg Med (1993) 3.07
Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry (2001) 3.05
cDNA cloning and structure of mouse putative Ah receptor. Biochem Biophys Res Commun (1992) 2.93
Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. J Biol Chem (1996) 2.92
Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J Cell Biol (1998) 2.81
Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol (1997) 2.79
PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression. Mol Cell (1998) 2.75
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene. Anal Biochem (1993) 2.74
Tumor angiogenesis in human lung adenocarcinoma. Cancer (1994) 2.59
Parthenogenetic activation of oocytes in c-mos-deficient mice. Nature (1994) 2.40
Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A (1991) 2.39
Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science (1996) 2.38
Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci U S A (1989) 2.38
Rho effectors and reorganization of actin cytoskeleton. FEBS Lett (1997) 2.19
Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med (1990) 2.15
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer (2008) 2.13
N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest (2000) 2.13
Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis (1990) 2.08
Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol (1995) 2.03
Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem (1986) 1.92
Accuracy and performance of the Terumo ES-H51, a new portable blood pressure monitor. Am J Hypertens (1994) 1.92
Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J Exp Med (1999) 1.88
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation (1992) 1.83
A patient with overlapping Bickerstaff's brainstem encephalitis, Miller Fisher syndrome and Guillain-Barré syndrome during the clinical course. Eur J Neurol (2002) 1.81
Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene (2007) 1.81
Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology (2005) 1.80
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol (1991) 1.78
Relation between critical illness polyneuropathy and axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1999) 1.78
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc (1991) 1.77
Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol (2008) 1.76
Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics. J Infect Dis (1982) 1.76
Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clin Chem (2001) 1.69
Cytomegalovirus DNA in the sera of patients with cytomegalovirus pneumonia. Br J Haematol (1991) 1.68
Acute facial diplegia and hyperreflexia: A Guillain-Barré syndrome variant. Neurology (2004) 1.68
Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase. Oncogene (1999) 1.68
The role of an alternative sigma factor in motility and pilus formation in the cyanobacterium Synechocystis sp. strain PCC6803. Proc Natl Acad Sci U S A (1999) 1.68
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer (2004) 1.67
Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology (2000) 1.66
Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiol Infect (1994) 1.64
The 'second-codon rule' and autophosphorylation govern the stability and activity of Mos during the meiotic cell cycle in Xenopus oocytes. EMBO J (1992) 1.63
Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem (1997) 1.62
Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD: a preliminary study. Thorax (2003) 1.61
A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects. J Biol Regul Homeost Agents (2008) 1.61
cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats. Circ Res (2001) 1.60
Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens (1997) 1.59
Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol (2008) 1.57
Fine specificity of anti-GQ1b IgG and clinical features. J Neurol Sci (2001) 1.53
Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med (1993) 1.52
Rho-dependent transfer of Citron-kinase to the cleavage furrow of dividing cells. J Cell Sci (2001) 1.50
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology (1992) 1.50
Suppression of IgE antibody production in SJL mice. I. Nonspecific suppressor T cells. J Exp Med (1976) 1.50
Establishment of medaka (Oryzias latipes) transgenic lines with the expression of green fluorescent protein fluorescence exclusively in germ cells: a useful model to monitor germ cells in a live vertebrate. Proc Natl Acad Sci U S A (2001) 1.48
Technetium-99m-tetrofosmin would be a substrate for multidrug resistance-associated protein (MRP): comparison between a leukemia cell line with high MRP gene expression and its parental cell line. Cancer Biother Radiopharm (2001) 1.48
Nuclear and cytosolic calcium are regulated independently. Proc Natl Acad Sci U S A (2003) 1.46
The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett (2000) 1.46
Bickerstaff's brainstem encephalitis subsequent to Campylobacter jejuni enteritis. J Neurol Neurosurg Psychiatry (2000) 1.46
Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res (1989) 1.46
Intracranial dural arteriovenous fistulas with retrograde cortical venous drainage: assessment with cerebral blood volume by dynamic susceptibility contrast magnetic resonance imaging. AJNR Am J Neuroradiol (2006) 1.46
Reproducibility of 99Tcm-MAG3 clearance in normal volunteers with the two-sample method: comparison with 131I-OIH. Nucl Med Commun (1998) 1.44
A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction. J Nucl Med (1999) 1.43
Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J (2001) 1.43
Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res (2000) 1.43
Prolonged survival of rat skin allograft by treatment with FK506 ointment. Transplantation (1997) 1.43
Correlation between cytomegalovirus infection and IgM anti-MAG/SGPG antibody-associated neuropathy. Ann Neurol (1998) 1.41
Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes (1997) 1.40
Suppression of IgE antibody production in SJL mice. II. Expression of Ly-1 antigen on helper and nonspecific suppressor T cells. J Immunol (1977) 1.40
The accuracy and performance of the A&D TM 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens (1992) 1.39
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. J Clin Oncol (2001) 1.39
Induction of anti-DNA antibodies by immunization with anti-DNA antibodies: mechanism and characterization. Lupus (2000) 1.39
FK506 treatment of noninfectious uveitis. Am J Ophthalmol (1994) 1.38
Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology (2005) 1.37
Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res (2001) 1.36
Highly bright X-ray generator using heat of fusion with a specially designed rotating anticathode. J Synchrotron Radiat (2008) 1.36
Antigen and antibody detection by in vivo methods; a reevaluation of passive cutaneous anaphylactic reactions. J Immunol Methods (1977) 1.35
Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens (1997) 1.34
Forest bathing enhances human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol (2007) 1.34
Localization of a mammalian homolog of diaphanous, mDia1, to the mitotic spindle in HeLa cells. J Cell Sci (2001) 1.33
Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J Immunol (1990) 1.32
canoe encodes a novel protein containing a GLGF/DHR motif and functions with Notch and scabrous in common developmental pathways in Drosophila. Genes Dev (1995) 1.31
Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology (2006) 1.30
UCN-01 abrogates G2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase. J Biol Chem (1998) 1.30
The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression. J Cell Sci (1999) 1.29
Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology (2001) 1.29